Breaking News
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
October 15, 2018 - Engineering teratoma-derived fibroblasts to enhance osteogenesis
October 15, 2018 - Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism
October 15, 2018 - JCU study firms up association between diet and depression
October 15, 2018 - Researchers to study the use of CRISPR on human liver on-a-chip platform
October 15, 2018 - Sub-concussive impacts not associated with decline in neurocognitive function
October 15, 2018 - Researchers find potential treatment to halt premature labor and birth
October 15, 2018 - As U.S. suicides rates rise, Hispanics show relative immunity
October 15, 2018 - FDA Issues a Complete Response Letter to Acacia Pharma for Barhemsys
October 15, 2018 - Photoactive bacteria bait may help in fight against MRSA infections
October 15, 2018 - Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children
October 15, 2018 - First-of-its-kind study to test a personalized vaccine in cancer patient
October 15, 2018 - Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia
October 15, 2018 - Half of parents say young children are afraid of doctor’s visits
October 15, 2018 - Study shows how fingerprint-based drug screening works on the living and deceased
October 15, 2018 - Study reveals potential to monitor progression of Alzheimer’s disease by measuring brain antioxidant levels
October 15, 2018 - FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
October 15, 2018 - Promising new therapeutic approach against Ebola virus identified
October 15, 2018 - Study unravels how cancer stem cells use normal genes in abnormal ways
October 15, 2018 - Healthcare systems fail to deliver at affordable prices finds report
October 15, 2018 - Intensive BP Therapy in Diabetes May Lower Risk for CV Events
October 15, 2018 - Muscle relaxants increase risk of respiratory complications
October 15, 2018 - Female birds become more promiscuous after hatchings fail in the first breeding attempt
October 15, 2018 - Humans occupied Madagascar thousands of years later than previously thought
October 15, 2018 - Is Kidney Dialysis Always Needed When Septic Shock Strikes?
October 15, 2018 - Study shows invasive lung cancer surgery can lead to long-term opioid use
October 15, 2018 - Sugar, a “sweet” tool to understand brain injuries
October 14, 2018 - King’s commemorates activities and research on World Arthritis Day
October 14, 2018 - Humana and VFW NY team up on Stop 22 initiative to increase awareness of veterans committing suicide
October 14, 2018 - Water fluoridation contributes to urinary fluoride levels in pregnant women in Canada
October 14, 2018 - Study of children in Romanian orphanages tells cautionary tale about family separation
October 14, 2018 - Previous Endologix AFX Safety Notice classified by FDA as Class I recall
October 14, 2018 - Legal scholars sound alarm on academies’ report about returning research results to participants
October 14, 2018 - UNIST selects six extraordinary scholars to be induced as ‘Rising-star Distinguished Professor’
October 14, 2018 - Scientists find new way to help asthmatics breathe more easily
October 14, 2018 - New ‘gag rule’ may adversely impact health care of pregnant women
October 14, 2018 - Rosacea – Genetics Home Reference
October 14, 2018 - When the fighting crosses the line
October 14, 2018 - New findings could benefit patients with triple-negative breast cancer
October 14, 2018 - UK Biobank provides wealth of information for further genetic studies
October 14, 2018 - KHN’s ‘What the Health?’ Falling premiums and rising political tensions
October 14, 2018 - Duvelisib Promising for Chronic Lymphocytic Leukemia, SLL
October 14, 2018 - Tailored drug cocktails offer hope to kids with aggressive brain tumors
October 14, 2018 - Common gene variants linked to migraine risk in African-American children
October 14, 2018 - Funding requests are being accepted by BlueCross BlueShield of Tennessee Community Trust
October 14, 2018 - Using pulsed electric fields in cancer therapy
October 14, 2018 - Major Childbirth Complications More Likely for Black Women
October 14, 2018 - Young cancer survivors at greater risk of mental health disorders
October 14, 2018 - Common herbicide compound could help fight hospital-acquired fungal infections
October 14, 2018 - Alterations in genes encoding proteins contribute to ADHD development
October 14, 2018 - New patient-centric website launched in Europe to empower people with chronic conditions
October 14, 2018 - Antimicrobial signaling molecule has lower activity against hepatitis C virus in most humans
October 14, 2018 - Genomic dark matter activity connects Parkinson’s and psychiatric diseases
October 14, 2018 - Cornell dots equipped with antibody fragments offer a new cancer weapon
October 14, 2018 - Addressing social and cultural factors is key to reducing burden of type 2 diabetes
October 14, 2018 - Study reveals why females age more slowly than males
October 14, 2018 - DNA vaccine shown to provide long-term protection from Ebola
October 14, 2018 - Gene therapy shown to remove core component of Parkinson’s disease
October 14, 2018 - Obamacare premiums dip for first time. Some call it a correction
October 14, 2018 - Scientists use haploid stem cells to produce mice with same-sex parents
October 14, 2018 - New transgenic mouse model sheds light on biological causes of Parkinson’s disease
Microbiologists contribute to possible new anti-TB treatment path

Microbiologists contribute to possible new anti-TB treatment path

image_pdfDownload PDFimage_print
The Morita lab at UMass Amherst is expert in investigating the multi-layered cell envelope components that surround mycobacteria. He sees the pathways that cells use to form these envelope layers as a promising path in the search for new drug targets in TB, which has seen increasing multi-drug resistance. Credit: UMass Amherst

As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita at the University of Massachusetts Amherst report that they have for the first time characterized a protein involved in making a glycolipid compound found in the TB cell wall, which is critical for the disease-causing Mycobacterium to become infectious.

Doctoral candidate and first author Kathryn Rahlwes, working with a non-pathogenic form of the bacterium in Morita’s lab, says, “We found mutant bacteria that were unable to express this protein. If they don’t have it, the enzymatic machinery they use to biosynthesize the glycolipid won’t work, and they cannot become infectious. We investigated a protein that had not been characterized before, nobody knew its role.” Details appear in the Journal of Biological Chemistry.

The Morita lab is expert in investigating the multi-layered cell envelope components that surround mycobacteria, including several glycolipids known or predicted to be essential for the overall viability of disease-causing Mycobacterium tuberculosis (Mtb), which have impermeable cell walls that block antibiotics. Morita sees the biosynthesis pathways that cells use to form these envelope layers as a promising path in the search for new drug targets in TB, a disease that has seen increasing multi-drug resistance.

He explains, “The protein that Kathryn characterized is part of the process by which these molecules trick the human immune system so that it doesn’t attack the bacteria as hard as it should, so they survive in the body. TB has many, many tricks and this is one of them. Understanding how the bacteria make these glycolipids might provide us a way to interfere with them and stop them from being able to infect us.”

For this work, Rahlwes used genetic screening methods to explore the mutant of Mycobacterium that contains the protein known as PimE. It had been identified earlier in the Morita lab and was known to have some unusual properties.

Morita explains, “We were growing some of the mutant Mycobacterium in a Petri dish, and they grew very poorly; the mutant colonies had a growth disadvantage. Then we isolated a mutant of the mutant, and these suddenly began growing well again. It didn’t make sense, and we became curious about what was going on. Why did one defect make them grow slowly and poorly, but two defects made them run normally again?”

It turns out that the “mutant mutant” has an initial growth defect plus another mutation in the same glycolipid biosynthesis pathway and the second mutation allows these bacteria to enjoy more normal growth. “This led us to the discovery of a new gene in the biosynthesis of this glycolipid, which we termed lipomannan elongation factor or LmeA,” Rahlwes says. “The mutated gene caused the production of different glycolipids in the mutant of the mutant.”

Next steps include trying to duplicate the mutant of this gene in the pathogenic form of mycobacteria, to demonstrate that the gene is indeed essential as predicted for infection to take place, the microbiologists say.

Rahlwes also plans to further investigate the protein’s role in the enzymatic pathway and which parts it is interacting with. “We know it’s involved, but not exactly what it’s doing,” she says. “We’d like to confirm its function in the pathogen and its impact on the pathogen’s growth. If it is essential for the pathogen to grow, and if we are able to deplete it in the pathogen, we will be able to interfere in the infection process.”


Explore further:
Mutant gene found to fuel cancer-promoting effects of inflammation

More information:
Kathryn C. Rahlwes et al, The cell envelope–associated phospholipid-binding protein LmeA is required for mannan polymerization in mycobacteria, Journal of Biological Chemistry (2017). DOI: 10.1074/jbc.M117.804377

Journal reference:
Journal of Biological Chemistry

Provided by:
University of Massachusetts Amherst

Tagged with:

About author

Related Articles